We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
Innate Pharma (IPHA) Edges Higher Near Key Support; Resistance at $1.88 in Focus - Breakaway Gap - dars.gov.et
Innate Pharma (IPHA) Edges Higher Near Key Support; Resistance at $1.88 in Focus - Breakaway Gap dars.gov.et
Innate Pharma(IPHA) Stock Options Chain | Quotes & News - Moomoo
Innate Pharma(IPHA) Stock Options Chain | Quotes & News Moomoo
Q1 2026 Innate Pharma SA Corporate Sales Call Transcript - GuruFocus
Q1 2026 Innate Pharma SA Corporate Sales Call Transcript GuruFocus
Price to book forward of Innate Pharma SA Class A – EURONEXT:IPH - TradingView
Price to book forward of Innate Pharma SA Class A – EURONEXT:IPH TradingView
Price to earnings forward of Innate Pharma SA Class A – EURONEXT:IPH - TradingView
Price to earnings forward of Innate Pharma SA Class A – EURONEXT:IPH TradingView
Price to sales forward of Innate Pharma SA Class A – EURONEXT:IPH - TradingView
Price to sales forward of Innate Pharma SA Class A – EURONEXT:IPH TradingView
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 13. | After market close (AMC) | — | — | — | $2.6M | — | Scheduled |
No research actions to show.
Price data
No holdings data to show.